Vivisum Partners

What Vivisum Partners does

Vivisum Partners is a privately-held, for-profit custom market research firm headquartered in Durham, United States. Founded in 2011, the company operates with a small team of 1-10 employees and is led by founder, president and CEO Dan Callahan. Its offering centers on custom market research services oriented toward brand building and the implementation of consumer or business insights intended to deliver high returns on investment for clients.

The firm positions itself within the boutique market research segment, focused on tailored research engagements rather than syndicated or platform-based products. Its functional emphasis is on insight implementation, suggesting services that extend beyond data collection into advisory and activation support for client brand and marketing decisions. There is no public indication of proprietary technology platforms, software products, self-service tools, or AI-driven automation in the supplied material.

Vivisum Partners is privately held with no public listing, ticker, or SEC filings referenced. No funding rounds, mergers and acquisitions, partnerships, awards, patents, leadership changes, or office expansion events are disclosed in the available data. The combination of a 14-year operating history, single named principal, small headcount, and absence of disclosed strategic activity paints a picture of a stable, founder-led consultancy whose public commercial footprint is minimal.

Name

Vivisum Partners

Legal name

ZoomRx Inc.

Website

https://vivisumpartners.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Vivisum Partners is a privately-held boutique market research firm founded in 2011 in Durham, United States. Operating with 1-10 employees under founder Dan Callahan, it delivers custom market research and insight implementation focused on brand building and client ROI.

Ownership category

akta.pro rank

Product category

Market Research Services

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Customer Experience (CX) & Voice-of-Customer Analytics (BPAHALAK)

akta.pro secondary industry

Customer Experience (CX) & Voice of Customer (NPS/CSAT, Journey Research) (MPAAALAH)

Keywords

• Custom market research
• Brand research
• Market intelligence
• Consumer insights
• Brand strategy

Headquarters

HQ city

Durham

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Strategic Life Sciences Consulting: Consulting services including launch excellence consulting, commercial analytics, and strategic market research consulting for pharma companies across drug lifecycle stages.
2. AI-Powered Insights Platforms: SaaS-style intelligence platforms (Ferma, Sagan) providing ongoing market intelligence, competitive monitoring, and research automation capabilities.
3. Primary Market Research: Tracking studies including Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Patient Chart Audits, HCP-Patient Conversation Research, and Media Tracking delivered as recurring studies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Vivisum Partners is a custom market research firm that designs and conducts tailored research programs to support brand building and insight implementation, with a stated focus on delivering high returns on client investments. The firm serves clients seeking targeted market intelligence to inform brand strategy and marketing decisions.

Product overview

ZoomRx is a strategic life sciences consulting firm and biopharma insights company offering an integrated platform of AI-powered solutions. The portfolio consists of two core AI platforms (Sagan Agents for conversational market research and Ferma for market intelligence), supported by a suite of primary market research methodologies (Promotional Effectiveness Tracking, Brand Tracking, Patient Chart Audits, Media Tracking, HCP-Patient Conversations), and strategic consulting services (Commercial Consulting, Launch Excellence, Market & Competitive Intelligence, Patient Insights). The AI capabilities are embedded throughout to accelerate data processing and deliver high-velocity pharma insights, while maintaining methodological rigor and authentic physician voices.

Differentiator

Problem solved

Functional benefit

Brands

• Sagan: AI-powered conversational survey platform transforming traditional pharma market research with human-powered, AI-enhanced primary research capabilities
• Ferma
• Patient Scribe
• Curie
• Promotional Effectiveness Tracking (PET)
• Brand Tracking (ATU)

Products and services

• Custom Market Research

Quantifiable outcome

• Trusted by 19 of the top 20 global pharma companies
• +1 more outcomes

Named customers16 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Scale indicators3 records

Direct peers

• Clarivate (Decision Resources Group): Owns Decision Resources Group, a long-established pharma market research and commercial intelligence firm serving similar biopharma customers with disease-level forecasting, market access insights, and competitive intelligence.
• Kantar Health: Healthcare-focused market research and insights division of Kantar, providing primary research, brand tracking, and patient/HCP insights to pharma — directly comparable to ZoomRx's PET and Brand Tracking offerings.
• Axtria: Pharma-focused cloud software and analytics company providing commercial operations, sales force effectiveness, and AI-driven insights for life sciences — competing in the same AI-augmented commercial analytics category as ZoomRx.
• ZS Associates: Global consulting firm focused on pharma and biotech commercial strategy, sales force effectiveness, and advanced analytics — directly overlapping ZoomRx's commercial consulting and AI-driven forecasting offerings.
• Putnam Associates: Strategy consulting firm exclusively focused on biopharma commercial strategy, market access, and launch excellence — closely comparable to ZoomRx's commercial consulting and launch insights offerings.
• Trinity Partners: Pharma strategy and insights consulting firm specializing in commercial strategy, market research, and analytics for biopharma — closely comparable to ZoomRx's core commercial consulting and primary research practice.
• Charles River Associates (Life Sciences): Life sciences consulting practice providing commercial strategy, market access, and pricing/forecasting support to pharma — directly comparable to ZoomRx's commercial consulting and forecasting work.
• IQVIA: Largest global provider of pharma market research, commercial analytics, and consulting, serving essentially the same top-20 pharma customer base. Competes head-to-head with ZoomRx across primary market research, RWE, and AI-driven insights.
• Informa Pharma Intelligence: Pharma market intelligence provider offering pipeline tracking, clinical trial data, and competitive intelligence — directly comparable to ZoomRx's Ferma platform for drug pipeline and congress intelligence.
• Definitive Healthcare: Healthcare commercial intelligence company providing data and analytics on HCPs, hospitals, and biopharma customers — adjacent comparable in commercial intelligence for life sciences.

Market position

Strengths5 records

Weaknesses5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/vivisumpartners
• YouTubeyoutube.com/@ZOOMRX
• Facebookfacebook.com/TeamZoomRx
• LinkedInlinkedin.com/company/zoomrx
• Instagraminstagram.com/zoomrx_official

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivisum Partners